Altered circadian feeding behavior and improvement of metabolic syndrome in obese Tac1-deficient mice

C A Maguire1, S León1, R S Carroll1

  • 1Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Abstract

Insights

Mice lacking the Tac1 gene exhibit reduced food intake and altered circadian rhythms, leading to leanness and improved metabolic health. Blocking substance P (SP) may offer a new therapeutic strategy for metabolic syndrome.

Area of Science:

  • Neuroendocrinology
  • Metabolic Regulation
  • Circadian Biology

Background:

  • Metabolic function relies on central and peripheral factors influencing food intake and energy expenditure.
  • Substance P (SP) is a novel, yet poorly understood, regulator of energy balance with conflicting data on its role in food intake.

Purpose of the Study:

  • To investigate the metabolic functions of Tac1 gene products, substance P (SP) and neurokinin A, in mice.
  • To characterize the effects of Tac1 deficiency on metabolism and feeding behavior.

Main Methods:

  • Genetic studies using Tac1-deficient mice (Tac1-/-).
  • Metabolic assessments including body weight, glucose tolerance, and insulin resistance.
  • Behavioral studies on feeding patterns and circadian rhythms.
  • Analysis of gene expression in the suprachiasmatic nucleus, hypothalamus, and liver.

Main Results:

  • Tac1-/- mice showed reduced food intake, leanness, and altered feeding circadian rhythms.
  • Tac1 deficiency improved glucose tolerance, prevented diet-induced insulin resistance, and enhanced brown adipose tissue activation.
  • Tac1 ablation in ob/ob mice partially ameliorated weight gain and reduced liver fat accumulation.

Conclusions:

  • Tac1 plays a crucial role in regulating circadian feeding behavior and metabolism via the melanocortin system.
  • Blocking substance P (SP) presents a potential therapeutic approach for metabolic syndrome.

Related Concept Videos